Matsunami General Hospital
Hashima Gun, Japan
General hospital in Kasamatsu
185-1 Dendai, Kasamatsu, Hashima District, Gifu 501-6062
About Matsunami General Hospital
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Bayer
2
Janssen Research & Development, LLC
2
Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan
2
AbbVie
1
Amgen
1
Clinical Trials at Matsunami General Hospital
During the past decade, Matsunami General Hospital conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 1 clinical trials were completed, i.e. on
average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Tegafur-Uracil or Observation in Treating Patients With Stage II Colorectal Cancer That Has Been Completely Removed By Surgery
2006-10-01
2016-09-01
Completed
2,025
Identifying Prognostic Factors in Patients Receiving Tegafur-Uracil for Stage II Colon Cancer That Was Completely Removed By Surgery
2006-10-01
2016-09-01
Completed
1,111
Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)
2010-10-27
2017-12-28
Completed
403
A Study of Molidustat for Correction of Renal Anemia in Dialysis Subjects
2018-01-22
2018-11-20
Completed
25
A Study of Guselkumab in Participants With Moderately to Severely Active Ulcerative Colitis
2019-09-26
2029-09-29
Active, not recruiting
1,064
Factor XI LICA to Reduce Events Such as Heart Attack and Stroke in Patients Whose Kidneys Are no Longer Able to Work as They Should and Require Treatment to Filter Wastes From the Blood: Focus is on the Safety of BAY2976217 and the Way the Body Absorbs, Distributes and Removes the Study Drug
2020-09-04
2022-05-12
Completed
307
A Study of Vaccination With 9-valent Extraintestinal Pathogenic Escherichia Coli Vaccine (ExPEC9V) in the Prevention of Invasive Extraintestinal Pathogenic Escherichia Coli Disease in Adults Aged 60 Years And Older With a History of Urinary Tract Infection in the Past 2 Years
2021-06-30
2028-05-14
Recruiting
18,556
Safety and Efficacy of Efavaleukin Alfa in Participants With Moderately to Severely Active Ulcerative Colitis
2022-01-31
2025-04-25
Recruiting
320
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Matsunami General Hospital" #1 sponsor was "Bayer" with 2 trials, followed by "Janssen Research & Development, LLC" with 2 trials
sponsored, "Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan" with 2 trials sponsored, "AbbVie" with 1 trials sponsored and "Amgen"
with 1 trials sponsored. Other sponsors include -5 different institutions and
companies that sponsored additional 5 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Matsunami General Hospital"
#1 collaborator was "Tokyo Medical and Dental University" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Matsunami General Hospital
According to Clinical.Site data, the most researched conditions in "Matsunami General Hospital" are
"Colorectal Cancer" (2 trials), "Ulcerative Colitis" (2 trials), "Anemia" (1 trials), "Ankylosing Spondylitis" (1 trials) and "End Stage Renal Disease Requiring Hemodialysis" (1 trials). Many other conditions were trialed in "Matsunami General Hospital" in a lesser frequency.
Clinical Trials Intervention Types at Matsunami General Hospital
Most popular intervention types in "Matsunami General Hospital" are "Drug" (6 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (4 trials), "UFT adjuvant chemotherapy" (2 trials), "BAY2976217" (1 trials), "Efavaleukin alfa" (1 trials) and "ExPEC9V" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Matsunami General Hospital
The vast majority of trials in "Matsunami General Hospital" are
8 trials for "All" genders.
Clinical Trials Status at Matsunami General Hospital
Currently, there are NaN active trials in "Matsunami General Hospital".
undefined are not yet recruiting,
2 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 5 completed trials in Matsunami General Hospital,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Matsunami General Hospital, 0 "Phase 1"
clinical trials were conducted, 3 "Phase 2" clinical
trials and 4 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".